118 related articles for article (PubMed ID: 29703475)
1. Novel strategies of coagulation inhibition for reducing tumor growth and angiogenesis.
Nadir Y; Brenner B
Thromb Res; 2018 Apr; 164 Suppl 1():S153-S156. PubMed ID: 29703475
[TBL] [Abstract][Full Text] [Related]
2. Heparanase procoagulant activity in cancer progression.
Nadir Y; Brenner B
Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
[TBL] [Abstract][Full Text] [Related]
3. Novel peptides that inhibit heparanase activation of the coagulation system.
Axelman E; Henig I; Crispel Y; Attias J; Li JP; Brenner B; Vlodavsky I; Nadir Y
Thromb Haemost; 2014 Sep; 112(3):466-77. PubMed ID: 25030319
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the heparanase procoagulant domain in bleeding and wound healing.
Crispel Y; Ghanem S; Attias J; Kogan I; Brenner B; Nadir Y
J Thromb Haemost; 2017 Jul; 15(7):1463-1472. PubMed ID: 28439967
[TBL] [Abstract][Full Text] [Related]
5. Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model.
Crispel Y; Axelman E; Tatour M; Kogan I; Nevo N; Brenner B; Nadir Y
Thromb Haemost; 2016 Sep; 116(4):669-78. PubMed ID: 27535490
[TBL] [Abstract][Full Text] [Related]
6. Decreasing Tumor Growth and Angiogenesis by Inhibition of Coagulation.
Nadir Y
Semin Thromb Hemost; 2019 Sep; 45(6):622-628. PubMed ID: 31398734
[TBL] [Abstract][Full Text] [Related]
7. Heparanase in the Coagulation System.
Nadir Y
Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
[TBL] [Abstract][Full Text] [Related]
8. Heparanase procoagulant effects and inhibition by heparins.
Nadir Y; Brenner B
Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
[TBL] [Abstract][Full Text] [Related]
9. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
10. Heparanase, tissue factor, and cancer.
Nadir Y; Vlodavsky I; Brenner B
Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
[TBL] [Abstract][Full Text] [Related]
11. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
12. Heparanase and coagulation-new insights.
Nadir Y
Rambam Maimonides Med J; 2014 Oct; 5(4):e0031. PubMed ID: 25386347
[TBL] [Abstract][Full Text] [Related]
13. Heparanase procoagulant activity.
Nadir Y; Brenner B
Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor-heparanase complex: intracellular nonhemostatic effects.
Ghanem S; Keren-Politansky A; Kaplan V; Crispel Y; Nadir Y
Res Pract Thromb Haemost; 2023 Aug; 7(6):102179. PubMed ID: 37767062
[TBL] [Abstract][Full Text] [Related]
15. An assay to evaluate heparanase procoagulant activity.
Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
[TBL] [Abstract][Full Text] [Related]
16. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
17. Heparanase procoagulant activity is elevated in women using oral contraceptives.
Matan M; Axelman E; Brenner B; Nadir Y
Hum Reprod; 2013 Sep; 28(9):2372-80. PubMed ID: 23800622
[TBL] [Abstract][Full Text] [Related]
18. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
19. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
[TBL] [Abstract][Full Text] [Related]
20. Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.
Nadir Y; Sarig G; Axelman E; Meir A; Wollner M; Shafat I; Hoffman R; Brenner B; Vlodavsky I; Haim N
Thromb Res; 2014 Sep; 134(3):639-42. PubMed ID: 25065557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]